{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:38:26Z","timestamp":1762875506036,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.thromres.2013.01.018","type":"journal-article","created":{"date-parts":[[2013,2,9]],"date-time":"2013-02-09T15:02:12Z","timestamp":1360422132000},"page":"304-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Commencement of warfarin therapy in children following the Fontan procedure"],"prefix":"10.1016","volume":"131","author":[{"given":"Elizabeth","family":"Crone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabila","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapna","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Hume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Newall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.thromres.2013.01.018_bb0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/heart.84.6.643","article-title":"Quality of life in children following mitral valve replacement","volume":"84","author":"van Doorn","year":"2000","journal-title":"Heart"},{"issue":"66","key":"10.1016\/j.thromres.2013.01.018_bb0010","first-page":"1","article-title":"The measurement of health-related quality of life in pediatric clinical trials: A systematic review","volume":"2","author":"Clarke","year":"2004","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.thromres.2013.01.018_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.thromres.2004.03.018","article-title":"Anticoagulation clinics for children achieve improved warfarin management","volume":"114","author":"Newall","year":"2004","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.thromres.2013.01.018_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1058-9813(02)00042-5","article-title":"Prevalence, clinical presentation and natural history of patients with single ventricle","volume":"16","author":"O'Leary","year":"2002","journal-title":"Prog Pediatr Cardiol"},{"issue":"5","key":"10.1016\/j.thromres.2013.01.018_bb0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/jpdn.2001.26573","article-title":"Current management of infants and children with single ventricle anatomy","volume":"16","author":"O'Brien","year":"2001","journal-title":"J Pediatr Nurs"},{"issue":"1","key":"10.1016\/j.thromres.2013.01.018_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ppedcard.2005.09.003","article-title":"Thrombosis in children with BT shunts, Glenns and Fontans","volume":"21","author":"Monagle","year":"2005","journal-title":"Prog Pediatr Cardiol"},{"issue":"3","key":"10.1016\/j.thromres.2013.01.018_bb0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0022-5223(98)70310-1","article-title":"Editorial: Thromboembolic Complications After Fontan Procedures--The Role Of Prophylactic Anticoagulation","volume":"115","author":"Monagle","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.thromres.2013.01.018_bb0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/adc.2006.113886","article-title":"A comparative study of anticoagulant control in patients on long-term warfarin using home and hospital monitoring of the international normalised ratio","volume":"93","author":"Bradbury","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.thromres.2013.01.018_bb0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/adc.74.3.228","article-title":"Oral anticoagulation in paediatric patients: dose requirements and complications","volume":"74","author":"Tait","year":"1996","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.thromres.2013.01.018_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.hrtlng.2006.06.002","article-title":"Health-related quality of life: a closer look at related research in patients who have undergone the Fontan operation over the last decade","volume":"36","author":"Pike","year":"2007","journal-title":"Heart Lung"},{"issue":"6","key":"10.1016\/j.thromres.2013.01.018_bb0055","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9343(00)00545-3","article-title":"Management and dosing of warfarin therapy","volume":"109","author":"Gage","year":"2000","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.thromres.2013.01.018_bb0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-0038-1642427","article-title":"Oral anticoagulation therpay in pediatric patients: a prospective study","volume":"71","author":"Andrew","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.01.018_bb0065","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V94.9.3007","article-title":"Analysis of Warfarin therapy in pediatric patients: a prospective cohort study of 319 patients","volume":"94","author":"Streif","year":"1999","journal-title":"Blood"},{"article-title":"Royal Children's Hospital, T. Anticoagulation Therapy Guideline","year":"2009","series-title":"Clinical Practice Guideline","key":"10.1016\/j.thromres.2013.01.018_bb0070"},{"issue":"7","key":"10.1016\/j.thromres.2013.01.018_bb0075","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/hrt.2004.039073","article-title":"Prophylactic anticoagulation following the Fontan operation","volume":"91","author":"Walker","year":"2005","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.thromres.2013.01.018_bb0080","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ijcard.2004.05.051","article-title":"Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure","volume":"102","author":"Cheung","year":"2005","journal-title":"Int J Cardiol"},{"year":"2006","series-title":"Andrew's Pediatric Thromboembolism and Stroke","author":"Monagle","key":"10.1016\/j.thromres.2013.01.018_bb0085"},{"key":"10.1016\/j.thromres.2013.01.018_bb0090","doi-asserted-by":"crossref","first-page":"344S","DOI":"10.1378\/chest.119.1_suppl.344S","article-title":"Antithrombotic therapy in children","volume":"119","author":"Monagle","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2013.01.018_bb0095","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/jcp.45.8.707","article-title":"Survey of oral anticoagulant treatment in children","volume":"45","author":"Evans","year":"1992","journal-title":"J Clin Pathol"},{"issue":"2 Suppl.","key":"10.1016\/j.thromres.2013.01.018_bb0100","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic Therapy in Neonates and Children","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"issue":"2, Supplement 1","key":"10.1016\/j.thromres.2013.01.018_bb0105","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/0049-3848(95)00231-6","article-title":"Indications and drugs for anticoagulation therapy in children","volume":"81","author":"Andrew","year":"1996","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.thromres.2013.01.018_bb0110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1055\/s-2004-815637","article-title":"Thrombosis in pediatric cardiac patients","volume":"29","author":"Monagle","year":"2003","journal-title":"Semin Thromb Hemost"},{"issue":"7","key":"10.1016\/j.thromres.2013.01.018_bb0115","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/hrt.2003.024299","article-title":"Anticoagulation in the young","volume":"90","author":"Monagle","year":"2004","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.thromres.2013.01.018_bb0120","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00246-007-9006-1","article-title":"Thromboembolism and the role of anticoagulation in the Fontan patient","volume":"28","author":"Jacobs","year":"2007","journal-title":"Pediatr Cardiol"},{"issue":"8","key":"10.1016\/j.thromres.2013.01.018_bb0125","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.105.576660","article-title":"Relationship of Patient and Medical Characteristics to Health Status in Children and Adolescents After the Fontan Procedure","volume":"113","author":"McCrindle","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.thromres.2013.01.018_bb0130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0003-4975(01)03068-5","article-title":"Fontan's operation: is aspirin enough? Is coumadin too much?","volume":"73","author":"Jacobs","year":"2002","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.thromres.2013.01.018_bb0135","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1440-1754.1998.00310.x","article-title":"Low dose oral anticoagulation therapy in Chinese children with congenital heart disease","volume":"34","author":"Cheung","year":"1998","journal-title":"J Paediatr Child Health"},{"issue":"2","key":"10.1016\/j.thromres.2013.01.018_bb0140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/hrt.78.2.154","article-title":"Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function","volume":"78","author":"Kaulitz","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2013.01.018_bb0145","series-title":"Congress of the International Society on Thrombosis and Haemostasis","article-title":"Pharmacogenetic expert dosing strategies (peds) for warfarin","author":"Bomgaars","year":"2011"},{"issue":"2","key":"10.1016\/j.thromres.2013.01.018_bb0150","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/j.thromres.2009.12.022","article-title":"Pediatric warfarin practice and pharmacogenetic testing","volume":"126","author":"Thornburg","year":"2010","journal-title":"Thromb Res"},{"issue":"6-Supplement","key":"10.1016\/j.thromres.2013.01.018_bb0155","doi-asserted-by":"crossref","first-page":"160s","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the Vitamin K anatgonists, American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th edition)","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.thromres.2013.01.018_bb0160","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/10245330500276451","article-title":"Patient understanding of warfarin therapy: A review of education strategies","volume":"10","author":"Newall","year":"2005","journal-title":"Hematology"},{"issue":"6","key":"10.1016\/j.thromres.2013.01.018_bb0165","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jacc.2011.01.061","article-title":"Randomized Trial Comparing Heparin\/Warfarin and Acetylsalicylic Acid as Primary Thromboprophylaxis for 2Years After the Fontan Procedure in Children","volume":"58","author":"Monagle","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.thromres.2013.01.018_bb0170","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.bdj.4810049","article-title":"Antibacterial prescribing and warfarin: a review","volume":"194","author":"Rice","year":"2003","journal-title":"Br Dent J"},{"issue":"6","key":"10.1016\/j.thromres.2013.01.018_bb0175","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/pbc.23308","article-title":"Risk factors for elevated INR values during warfarin therapy in hospitalized pediatric patients","volume":"58","author":"Moffett","year":"2012","journal-title":"Pediatr Blood Cancer"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:37:14Z","timestamp":1758735434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384813000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0049384813000200"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2013.01.018","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Commencement of warfarin therapy in children following the Fontan procedure","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2013.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}